barr 400mg 590 (Didanosine 400 mg)
Pill imprint barr 400mg 590 has been identified as Didanosine 400 mg.
Didanosine is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Didanosine 400 mg is not a controlled substance under the Controlled Substance Act (CSA).
- barr 400mg 590
- 400 mg
- Red & White
- 23.00 mm
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- Inactive Ingredients:
- ferrosoferric oxide
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
D&C Red No. 33
FD&C Yellow No. 6
|NDC Code||Manufacturer / Repackager|
|68084-0432||Amerisource Health Services|
|54569-5643||A-S Medication Solutions, LLC (repackager)|
|35356-0259||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.
More about didanosine
- Didanosine chewable/dispersible buffered tablets
- Didanosine delayed-release enteric-coated capsules
- Didanosine powder pack
- Didanosine solution
- Didanosine (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.